Welcome to our dedicated page for EnerSys SEC filings (Ticker: ENS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching a 300-page report to see how rising lead prices hit EnerSys’s Motive Power margins is time-consuming. The same goes for tracking when executives buy shares before a new lithium product rollout. Stock Titan solves these problems by translating dense disclosures into plain English, letting you grasp EnerSys insider trading Form 4 transactions without wading through technical jargon.
Our platform ingests every EnerSys quarterly earnings report 10-Q filing the moment it appears on EDGAR and delivers AI-powered summaries that spotlight segment revenue shifts, raw-material cost notes, and inventory turns. You’ll also find:
- Easily searchable EnerSys Form 4 insider transactions real-time alerts
- An “EnerSys annual report 10-K simplified” breakdown that connects strategy to cash flow
- Concise digests of each EnerSys 8-K material events explained within minutes of release
Need deeper context? Our AI answers natural questions—“understanding EnerSys SEC documents with AI” or “EnerSys proxy statement executive compensation” queries—by pointing you straight to the relevant tables and footnotes. Whether you’re comparing R&D spend across business units or monitoring EnerSys executive stock transactions Form 4 before earnings, Stock Titan keeps you ahead with:
- Real-time filing notifications across all form types
- Clear, accountant-vetted ratio analyses for each EnerSys earnings report filing analysis
- Downloadable data that integrates into your existing models
Stop scrolling, start knowing. EnerSys SEC filings explained simply—powered by Stock Titan’s AI.
Krystal Biotech, Inc. (KRYS) filed a Form 4 disclosing an insider equity award to director Christopher Mason.
- Type of security: Non-qualified stock option giving the right to purchase 5,000 shares of common stock.
- Exercise price: $137.46 per share.
- Grant date: 06/30/2025; expiration: 06/30/2035.
- Vesting schedule: Equal monthly tranches over one year (per the footnote).
- Ownership status after grant: 5,000 derivative securities held directly; no non-derivative share movement reported.
- The filing was signed by Krish Krishnan as attorney-in-fact for Mason.
No sales, purchases, or other changes in common-stock holdings were reported, and no Rule 10b5-1 plan was indicated.
On June 27, 2025, Chad C. Uplinger—President, Motive Power Global at EnerSys (ENS)—filed a Form 4 reporting automatic acquisitions of 27.758 restricted stock units (RSUs). The RSUs represent dividend-equivalent grants linked to four separate unvested RSU awards originally granted between 2021 and 2024. Each credit carried a $0 acquisition cost and reflects the cash dividend paid on June 27, 2025 to shareholders of record as of June 13, 2025. After the transactions, Uplinger directly owns approximately 17,573 EnerSys common shares. The filing, signed on June 30, 2025, involves no sales, options, or derivative activity and does not alter the insider’s reporting status.
UBS AG London Branch is offering $7.848 million of Capped Leveraged Buffered Medium-Term Notes linked to the S&P 500® Index, maturing on 24 February 2027 (about 20 months).
The notes pay no periodic interest. Instead, investors receive a cash payment at maturity determined as follows:
- Upside: 180% participation in any index gain, capped at a maximum settlement amount of $1,195.66 per $1,000 note (a 19.566% absolute cap, reached if the index closes ≥110.87% of its initial level).
- Neutral zone: If the index is flat or down by ≤12.50%, investors receive full principal.
- Downside: If the index falls by >12.50%, principal is reduced at an effective rate of 1.1429% for every additional 1% decline (i.e., exposure of 114.29% beyond the 12.5% buffer). A full loss of principal is possible.
Key terms: initial index level 6,025.17; buffer level 5,272.02375 (87.5%); estimated initial value $997.50; underwriting discount 0%; issue price 100%; trade date 23 June 2025; settlement 30 June 2025. The notes will not be listed and UBS Securities LLC will act as calculation agent and market-maker, but is not obliged to provide liquidity.
Cost transparency: The estimated value ($997.50) is below the $1,000 issue price, reflecting embedded hedging, funding and distribution costs. Any secondary-market bid is expected to exceed the internal model value only for up to three months, then converge.
Risk highlights: Investors face the unsecured credit risk of UBS AG; limited upside due to the cap; potential loss of capital below the 12.5% buffer; illiquidity; complex U.S. tax treatment (Section 871(m) and FATCA); and possible regulatory or resolution actions by FINMA that could impair payments.
Suitability: The product targets investors who 1) are moderately bullish on the S&P 500, 2) can tolerate loss of principal, 3) value a modest downside buffer, and 4) are willing to hold to maturity without dividends.
EnerSys (ENS) – Form 4 filing: President, Specialty & Interim CTO Mark E. Matthews reported four separate acquisitions on 27 June 2025. The transactions reflect 27.1567 additional restricted stock units (RSUs) that were automatically credited in connection with EnerSys’ cash dividend paid on 27 June 2025. No cash was exchanged (price = $0.00) and the RSUs vest concurrently with the underlying awards granted between 2021-2024. Matthews’ total direct beneficial ownership rose from roughly 16,864.7 shares to 16,891.8 shares. Because these are dividend-equivalent grants rather than open-market purchases, the economic impact is minimal but maintains management’s equity alignment with shareholders.
EnerSys EVP & Chief Financial Officer Andrea J. Funk filed a Form 4 reporting a series of five automatic stock acquisitions on 27 June 2025. The transactions reflect dividend-equivalent credits on previously granted Restricted Stock Units (RSUs) and therefore carried a price of $0.00 per share. In total, 102.4125 common shares were added to Funk’s direct holdings, lifting her ownership to 50,747.4367 shares.
The RSU dividend equivalents relate to grants originally awarded on 16 Aug 2021 (1,386 RSUs), 12 Aug 2022 (4,445 RSUs), 11 Aug 2023 (4,946 RSUs), 9 Aug 2024 (7,499 RSUs) and 23 May 2025 (18,746 RSUs). Each incremental RSU will vest and be settled concurrently with its underlying grant, mirroring the terms already in place. No derivative securities were exercised or disposed of, and there were no sales of EnerSys shares.
Because the shares stem from routine dividend adjustments and represent less than 0.3% of total personal holdings, the filing is considered administrative and non-material from a valuation perspective. Nevertheless, the absence of sales and continual share accumulation marginally reinforces management’s alignment with shareholder interests.
EnerSys (ticker ENS) filed a Form 4 disclosing that Keith D. Fisher, President of Energy Systems Global, received a small number of additional common shares through dividend-equivalent Restricted Stock Units (RSUs) on 27 Jun 2025. Two separate entries show acquisitions of 13.9434 and 34.8585 RSUs, both at a price of $0.00, tied to the company’s cash dividend paid the same day. After the transactions, Fisher’s direct beneficial ownership rose from 17,608.29 to 17,643.15 shares. The RSUs will vest concurrently with the underlying February 7 2025 awards. No open-market purchases, sales, or derivative exercises were reported.
The filing represents routine dividend-equivalent adjustments rather than a deliberate insider purchase or sale, and the aggregate increase (~49 shares) is immaterial relative to EnerSys’s outstanding share count.
The Form 4 filing discloses that Hannah A. Valantine, M.D., a director of BridgeBio Pharma, Inc. (BBIO), sold a total of 4,707 shares of BBIO common stock on 26-Jun-2025 at weighted-average prices ranging from $44.01 to $44.14 per share.
- Direct holdings: Two separate sales of 876 shares (avg. $44.1099) and 1,542 shares (avg. $44.01) reduced Dr. Valantine’s direct ownership from 9,883 shares to 7,465 shares.
- Indirect (spousal) holdings: Two sales of 398 shares (avg. $44.1263) and 1,891 shares (avg. $44.0303) lowered spousal indirect holdings from 2,687 shares to 398 shares.
- Total remaining beneficial ownership: 7,863 shares (7,465 direct + 398 indirect).
- The filing uses transaction code “S” indicating open-market sales. Weighted-average price ranges are provided; detailed price breakdowns are available upon request, per footnotes 1 and 2.
No derivative security transactions were reported. No 10b5-1 trading plan is indicated, and there are no acquisitions or option exercises in this filing.
The magnitude of the sale represents a partial reduction of the director’s position rather than a complete exit, and the company’s overall share count is unaffected. The information is limited to insider activity; it does not include operational or financial performance data.
Form 4 filing for Teradyne, Inc. (TER) dated 06/30/2025: Director Paul J. Tufano elected to defer a portion of his quarterly cash compensation into 521 deferred stock units (DSUs) on 06/26/2025. The DSUs convert one-for-one into common stock, typically within 90 days after Mr. Tufano ceases to serve as a non-employee director. The transaction is coded “A” (acquisition) at $0 cost, lifting his direct beneficial ownership to 64,163 TER shares. No derivative securities were reported. The filing indicates routine director compensation activity and does not involve open-market purchases or sales.
EnerSys (ENS) Form 4 filing: Director Rudolph W. Wynter reported automatic grants of dividend-equivalent equity units on 27 June 2025. The transactions comprise 20.7943 vested Deferred Stock Units (DSUs) and 11.0929 vested Restricted Stock Units (RSUs), plus 0.4726 unvested RSUs spread across four prior award dates. All units were issued at $0.00 cost as part of the company’s cash-dividend adjustment mechanism for non-employee directors. Following the issuances, Wynter’s direct beneficial ownership increased to 11,527.3249 common shares.
The filing reflects routine dividend-equivalent adjustments rather than discretionary purchases or sales, and does not involve any derivative securities. No changes to board roles or compensation terms were disclosed.
EnerSys (ENS) Form 4 filing overview: Director Tamara Morytko reported automatic acquisitions of a total of ~19.47 EnerSys common shares on 27 June 2025. The shares were issued as dividend-equivalent Deferred Stock Units (DSUs) and Restricted Stock Units (RSUs) tied to previously granted equity awards under the company’s Deferred Compensation Plan for Non-Employee Directors.
- The transactions were coded “A” (acquired) at a price of $0.00, reflecting non-cash issuance.
- Following the adjustments, Morytko’s direct beneficial ownership increased to 7,036.7226 shares.
- The filing does not involve open-market purchases, sales or derivative exercises; it simply records routine dividend adjustments.
Investment relevance: The fractional share increase is immaterial relative to EnerSys’s ~40 million outstanding shares and does not signal a change in insider sentiment. It does, however, confirm the director’s continuing equity alignment through the dividend-protected RSU/DSU program.